ALPHACENTRIC ADVISORS LLC – TCR2 Therapeutics Inc. Transaction History
ALPHACENTRIC ADVISORS LLC portfolio value:
$272,000
portfolio value
ALPHACENTRIC ADVISORS LLC quarter portfolio value change:
-62.42%
quarter
TCR2 Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -432K | $1.8 | 151K | |
| Q4 2021 | share | Increase | +33.63% | 38K shares | -258K | $4.79 | 151K |
| Q3 2021 | share | Increase | +175.61% | 72K shares | 289K | $8.51 | 113K |
| Q2 2021 | share | Increase | +645.45% | 35.5K shares | 552K | $16.41 | 41K |
| Q1 2021 | share | Increase | +141.76% | 3.22K shares | 51K | $22.08 | 5.5K |
| Q4 2020 | share | Increase | +19.74% | 375 shares | 31K | $30.93 | 2.27K |
| Q3 2020 | share | Increase | 0.00% | 1.9K shares | 39K | $20.32 | 1.9K |